Both medicines are administered as subcutaneous injections, typically once weekly, and are still undergoing large-scale clinical trials
Wegovy (semaglutide) is an FDA-approved medication for chronic weight management in adults with obesity or are overweight who also have weight-related medical conditions
Founds health care providers, trained in obesity medicine, can help patients identify the root cause of their weight gain and personalize a prescription to target it
Access Data FDA , Food and Drug Administration, revised 2023
Take it whenever convenient
Targeting intermediary metabolism Farnesoid X receptor (FXR) agonists The nuclear FXR agonists may treat MASLD through various mechanisms, including alleviating insulin resistance and exerting direct anti-inflammatory and antifibrotic effects on MASH in both mouse models and human tissues